Sarah’s interview was definitely devoid of substance. In a way, she made the right points and critical observations (like how Remeo requires country-specific registrations in the EU for everything, even the instruments used to install implants), but it felt like she just wanted to talk about things in a positive tone even though the room is on fire.
Someone asked a clear question about how much revenue has been generated through Remeo so far. Sarah gave what must have been a 2-minute monologue and dodged answering the question directly. Why the hell can’t she just give the Euro amount; whatever the amount—it would be quite desirable to start being brutally transparent about everything.
Once again, there was a lot of promotion for the right recruits and investment in growth. I have to admit that I couldn’t care less about how much the company “invests in growth.” In Retec’s case, I’d be interested in the growth itself instead of growth investments. So, not that babble again about how “we have burned money and assume that it will eventually turn into revenue,” but honest revenue on the table. It’s about high time. Could those damn investments finally start to wind down and the cash flow get moving.